...
首页> 外文期刊>Macromolecular Research >Preparation and characterization of water-soluble microcapsule for sustained drug release using Eudragit RS 100
【24h】

Preparation and characterization of water-soluble microcapsule for sustained drug release using Eudragit RS 100

机译:使用Eudragit RS 100制备并表征用于持续释放药物的水溶性微胶囊

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, ondansetron was encapsulated using hydroxypropyl methyl cellulose (HPMC) mixed with a water-insoluble polymeric barrier using EuRS RS 100 (EuRS), which was expected to be effective in preventing premature drug release. This microcapsule containing ondansetron was prepared using oil-in-water (O/W) solvent evaporation method and confirmed by Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). The morphology and particle size of the microcapsules were observed by scanning electron microscopy (SEM). In addition, the drug release behavior of the microcapsules with different EuRS contents were determined by UV/Vis spectroscopy. From the results, the microcapsules were successfully fabricated in all cases, 28–49 μm in size. The drug release rate was decreased with increasing EuRS ratio, which was likely due to the increasing content of quaternary ammonium groups on EuRS.
机译:在这项研究中,使用羟丙基甲基纤维素(HPMC)和不溶于水的聚合物屏障(使用EuRS RS 100(EuRS)混合)将恩丹西酮包封,这有望有效防止药物过早释放。使用水包油(O / W)溶剂蒸发法制备含有恩丹西酮的微胶囊,并通过傅里叶变换红外光谱(FTIR)和X射线衍射(XRD)进行确认。通过扫描电子显微镜(SEM)观察微胶囊的形态和粒径。另外,通过UV / Vis光谱法确定具有不同EuRS含量的微胶囊的药物释放行为。从结果可知,在所有情况下都成功制造了微胶囊,尺寸为28-49μm。药物释放速率随EuRS比率的增加而降低,这可能是由于EuRS上季铵基团含量的增加所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号